Loading...
Loading...
India's insulin imports from GERMANY total $87.0B across 489 shipments from 15 foreign suppliers. SANOFI-AVENTIS SINGAPORE PTE LTD leads with $86.8B in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include SANOFI INDIA LIMITED. This corridor reflects India's pharmaceutical import demand for insulin — a diversified sourcing base with multiple active suppliers from GERMANY.

SANOFI-AVENTIS SINGAPORE PTE LTD is the leading Insulin supplier from GERMANY to India, with import value of $86.8B across 220 shipments. The top 5 suppliers — SANOFI-AVENTIS SINGAPORE PTE LTD, SANOFIAVENTIS SINGAPORE PTE L, ELI LILLY EXPORT S.A., SANOFI-AVENTIS SINGAPORE PTE LIMITED, ROCHE DIAGNOSTICS INTERNATIONAL LTD — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | SANOFI-AVENTIS SINGAPORE PTE LTD | $86.8B | 220 | 99.7% |
| 2 | SANOFIAVENTIS SINGAPORE PTE L | $154.4M | 44 | 0.2% |
| 3 | ELI LILLY EXPORT S.A. | $35.9M | 9 | 0.0% |
| 4 | SANOFI-AVENTIS SINGAPORE PTE LIMITED | $33.7M | 68 | 0.0% |
| 5 | ROCHE DIAGNOSTICS INTERNATIONAL LTD | $882.9K | 84 | 0.0% |
| 6 | SANOFI AVENTIS SINGAPORE PTE LTD | $194.7K | 4 | 0.0% |
| 7 | SANOFI AVENTIS SINGAPORE PT LTD | $156.7K | 2 | 0.0% |
| 8 | ELI LILLY EXPORT S A | $49.1K | 2 | 0.0% |
| 9 | ROCHE DIAGNOSTICS INTERNATIONAL LIMITED | $29.5K | 29 | 0.0% |
| 10 | ORGENTEC Diagnostika GmbH | $12.4K | 20 | 0.0% |
| 11 | ROCHE DIAGNOSTICS GMBH | $3.1K | 2 | 0.0% |
| 12 | GNH PHARMACEUTICALS USA LLC | $2.4K | 1 | 0.0% |
| 13 | NOVO NORDISK A S | $937 | 1 | 0.0% |
| 14 | DEUTSCHE HOMOOPATHIE-UNION | $392 | 2 | 0.0% |
| 15 | INTERVET INTERNATIONAL B V | $3 | 1 | 0.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | SANOFI INDIA LIMITED | $87.0B | 328 | 100.0% |
| 2 | ELI LILLY AND COMPANY (INDIA ) PRIVATE LIMITED | $35.9M | 9 | 0.0% |
| 3 | ROCHE DIAGNOSTICS INDIA PRIVATE LIMITED | $915.5K | 115 | 0.0% |
| 4 | SANOFI HEALTHCARE INDIA PRIVATE LIMITED | $425.5K | 10 | 0.0% |
| 5 | ELI LILLY AND COMPANY INDIA PRIVATE LIMITED | $49.1K | 2 | 0.0% |
| 6 | SEBIA DIAGNOSTICS INDIA PRIVATE LIMITED | $12.4K | 20 | 0.0% |
| 7 | PROCELL BIOLOGICS PRIVATE LIMITED | $2.4K | 1 | 0.0% |
| 8 | TORRENT PHARMACEUTICALS LTD | $937 | 1 | 0.0% |
| 9 | DR WILLMAR SCHWABE INDIA PRIVATE LIMITED | $392 | 2 | 0.0% |
| 10 | INTERVET INDIA PRIVATE LIMITED | $3 | 1 | 0.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Insulin suppliers from GERMANY to India include SANOFI-AVENTIS SINGAPORE PTE LTD, SANOFIAVENTIS SINGAPORE PTE L, ELI LILLY EXPORT S.A.. The leading supplier is SANOFI-AVENTIS SINGAPORE PTE LTD with import value of $86.8B USD across 220 shipments. India imported Insulin worth $87.0B USD from GERMANY in total across 489 shipments.
India imported Insulin worth $87.0B USD from GERMANY across 489 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Insulin sourced from GERMANY include SANOFI INDIA LIMITED, ELI LILLY AND COMPANY (INDIA ) PRIVATE LIMITED, ROCHE DIAGNOSTICS INDIA PRIVATE LIMITED. The largest buyer is SANOFI INDIA LIMITED with $87.0B in imports across 328 shipments.
The total value of Insulin imports from GERMANY to India is $87.0B USD, across 489 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
489 Verified Shipments
15 suppliers, 10 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists